182 related articles for article (PubMed ID: 8226784)
1. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.
Morice WG; Wiederrecht G; Brunn GJ; Siekierka JJ; Abraham RT
J Biol Chem; 1993 Oct; 268(30):22737-45. PubMed ID: 8226784
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW
J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes.
Morice WG; Brunn GJ; Wiederrecht G; Siekierka JJ; Abraham RT
J Biol Chem; 1993 Feb; 268(5):3734-8. PubMed ID: 8429048
[TBL] [Abstract][Full Text] [Related]
4. Effects of iron-depletion on cell cycle progression in normal human T lymphocytes: selective inhibition of the appearance of the cyclin A-associated component of the p33cdk2 kinase.
Lucas JJ; Szepesi A; Domenico J; Takase K; Tordai A; Terada N; Gelfand EW
Blood; 1995 Sep; 86(6):2268-80. PubMed ID: 7662974
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin.
Aagaard-Tillery KM; Jelinek DF
Cell Immunol; 1994 Jul; 156(2):493-507. PubMed ID: 7517796
[TBL] [Abstract][Full Text] [Related]
6. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2.
Poon RY; Yamashita K; Adamczewski JP; Hunt T; Shuttleworth J
EMBO J; 1993 Aug; 12(8):3123-32. PubMed ID: 8393783
[TBL] [Abstract][Full Text] [Related]
7. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration.
Loyer P; Glaise D; Cariou S; Baffet G; Meijer L; Guguen-Guillouzo C
J Biol Chem; 1994 Jan; 269(4):2491-500. PubMed ID: 8300575
[TBL] [Abstract][Full Text] [Related]
8. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
Tsai LH; Lees E; Faha B; Harlow E; Riabowol K
Oncogene; 1993 Jun; 8(6):1593-602. PubMed ID: 8502482
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
Nourse J; Firpo E; Flanagan WM; Coats S; Polyak K; Lee MH; Massague J; Crabtree GR; Roberts JM
Nature; 1994 Dec; 372(6506):570-3. PubMed ID: 7990932
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor regulates the expression and activity of p33cdk2 and p34cdc2 kinases in PC12 pheochromocytoma cells.
Buchkovich KJ; Ziff EB
Mol Biol Cell; 1994 Nov; 5(11):1225-41. PubMed ID: 7865886
[TBL] [Abstract][Full Text] [Related]
11. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
Terada N; Franklin RA; Lucas JJ; Blenis J; Gelfand EW
J Biol Chem; 1993 Jun; 268(16):12062-8. PubMed ID: 8389370
[TBL] [Abstract][Full Text] [Related]
12. The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines.
Kawamata S; Sakaida H; Hori T; Maeda M; Uchiyama T
Blood; 1998 Jan; 91(2):561-9. PubMed ID: 9427710
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of the immunosuppressant rapamycin.
Dumont FJ; Su Q
Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
[TBL] [Abstract][Full Text] [Related]
14. Temporal regulation of cyclin A-p107 and p33cdk2 complexes binding to a human thymidine kinase promoter element important for G1-S phase transcriptional regulation.
Li LJ; Naeve GS; Lee AS
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3554-8. PubMed ID: 8475104
[TBL] [Abstract][Full Text] [Related]
15. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
Gollapudi L; Neet KE
J Neurosci Res; 1997 Aug; 49(4):461-74. PubMed ID: 9285522
[TBL] [Abstract][Full Text] [Related]
16. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.
Tsai LH; Harlow E; Meyerson M
Nature; 1991 Sep; 353(6340):174-7. PubMed ID: 1653904
[TBL] [Abstract][Full Text] [Related]
17. Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs.
Rhodes N; Innes CL; Propst F; Paules RS
Oncogene; 1997 Jun; 14(25):3017-27. PubMed ID: 9223665
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
Pan ZQ; Amin A; Hurwitz J
J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes.
Firpo EJ; Koff A; Solomon MJ; Roberts JM
Mol Cell Biol; 1994 Jul; 14(7):4889-901. PubMed ID: 7516474
[TBL] [Abstract][Full Text] [Related]
20. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line.
Albers MW; Williams RT; Brown EJ; Tanaka A; Hall FL; Schreiber SL
J Biol Chem; 1993 Oct; 268(30):22825-9. PubMed ID: 8226793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
